The stock of Unitedhealth Group Inc (NYSE:UNH) last traded at $470.38, up 1.92% from the previous session.
UNH stock price is now -9.20% away from the 50-day moving average and -14.01% away from the 200-day moving average. The market capitalization of the company currently stands at $432.88B.
With the price target maintained at $595, HSBC Securities recently Upgraded its rating from Hold to Buy for Unitedhealth Group Inc (NYSE: UNH). On January 06, 2025, Truist reiterated its ‘Buy’ rating on the stock by increasing its target price from $625 to quote $610, while ‘HSBC Securities’ rates the stock as ‘Hold’
In other news, FLYNN TIMOTHY PATRICK, Director bought 1,000 shares of the company’s stock on Jan 17 ’25. The stock was bought for $511,575 at an average price of $511.57. Upon completion of the transaction, the Director now directly owns 4,500 shares in the company, valued at $2.12 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, EVP & Chief People Officer McSweeney Erin sold 701 shares of the business’s stock. A total of $438,987 was realized by selling the stock at an average price of $626.23. This leaves the insider owning 7,105 shares of the company worth $3.34 million. A total of 0.22% of the company’s stock is owned by insiders.
During the past 12 months, Unitedhealth Group Inc has had a low of $436.38 and a high of $630.73.
The net profit margin was 3.60% and return on equity was 15.99% for UNH. The company reported revenue of $100.81 billion for the quarter, compared to $94.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.76 percent. For the current quarter, analysts expect UNH to generate $111.53B in revenue.
